Science Explorer Back to mapMap
Discussion
Researcher · Inserm · France

Jean Paul Soulillou

Jean Paul Soulillou publishes mostly in Immunology, Transplantation and Surgery, on topics such as Renal Transplantation Outcomes and Treatments, T-cell and B-cell Immunology and Immune Cell Function and Interaction.

OpenAlex
World rank
#4,870,486
of 7,710,434 ranked researchers
Rank in France
#205,237
of 324,115
Works
67
Citations
990
Citations per work
14.8
h-index
17
i10-index 29Top 40% in Immunology
Jean Paul Soulillou

What does Jean Paul Soulillou research?

Jean Paul Soulillou's work is mostly in Medicine (39%), Immunology and Microbiology (24%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 26 works · 39.0% of their workMedicine: 26 works · 39.0% of their workTransplantation: 11 works · 16.3% of their workSurgery: 9 works · 13.7% of their workNephrology: 4 works · 5.8% of their workOncology: 2 works · 3.2% of their workLife Sciences: 21 works · 31.0% of their workImmunology and Microbiology: 16 works · 24.2% of their workImmunology: 16 works · 24.2% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 6.8% of their workMolecular Biology: 5 works · 6.8% of their workEverything else: 20 works · 30.0% of their workTHEIR WORKJean PaulSoulillou67works
Life Sciences31%Health Sciences39%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2639.0%
    1. Immunology and Microbiology1624.2%
    2. Biochemistry, Genetics and Molecular Biology56.8%
  3. Everything else2030.0%
  1. 1Immunology24% of their works
  2. 2Transplantation16% of their works
  3. 3Surgery14% of their works
  4. 4Molecular Biology7% of their works
  5. 5Nephrology6% of their works
  6. 6Oncology3% of their works

Research topics

Which keywords describe Jean Paul Soulillou's research?

The keywords of their largest research topics: Graft Survival, Kidney Transplantation, Renal Allograft, Foxp3, TGF-ß, Ischemia-Reperfusion Injury, Liver Transplantation and Natural Killer Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Graft Survival452 topics
  2. Kidney Transplantation301 topic
  3. Renal Allograft301 topic
  4. Foxp3161 topic
  5. TGF-ß161 topic
  6. Ischemia-Reperfusion Injury151 topic
  7. Liver Transplantation151 topic
  8. NK Cell Recognition151 topic
  9. Natural Killer Cells151 topic
  10. Cancer Immunotherapy112 topics
  11. Glomerular Diseases111 topic
  12. Nephrotic Syndrome111 topic
  13. Dendritic Cells61 topic
  14. Immunity61 topic
  15. CAR T Cells51 topic
  16. Chimeric Antigen Receptor51 topic
  17. Rejection51 topic
  18. Transplantation51 topic

Where does Jean Paul Soulillou work?

Jean Paul Soulillou's main affiliation in the publication record is Inserm, France.

How many publications and citations does Jean Paul Soulillou have?

OpenAlex counts 67 works and 990 citations for Jean Paul Soulillou, an h-index of 17, ranking #4,870,486 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Jean Paul Soulillou

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jean Paul Soulillou. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.